We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

104 hedge funds and large institutions have $1.15B invested in Epizyme, Inc in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 24

52% more call options, than puts

Call options by funds: $5.2M | Put options by funds: $3.42M

52% more capital invested

Capital invested by funds: $757M → $1.15B (+$393M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4% less funds holding

Funds holding: 108 → 104 (-4)

22% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 18

Holders
104
Holders Change
-4
Holders Change %
-3.7%
% of All Funds
2.59%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
14
Increased
48
Reduced
24
Closed
18
Calls
$5.2M
Puts
$3.42M
Net Calls
+$1.78M
Net Calls Change
+$1.44M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$68.6M
2
Primecap Management
Primecap Management
California
+$26.4M
3
RG
Redmile Group
California
+$18.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$14.1M
5
PAI
Palo Alto Investors
California
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
CC
CQS Cayman
Cayman Islands
-$9.28M
2
CC
Casdin Capital
New York
-$7.85M
3
State Street
State Street
Massachusetts
-$2.9M
4
GTC
Ghost Tree Capital
New York
-$2.27M
5
OAM
Oxford Asset Management
United Kingdom
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$5.52M +$1.01M +66,071 +30%
EAM
27
Eventide Asset Management
Massachusetts
$5.24M – – –
LCM
28
Laurion Capital Management
New York
$4.53M +$3.63M +237,859 New
RPAM
29
Rhenman & Partners Asset Management
Sweden
$4.5M -$242K -15,843 -6%
BBA
30
Baker Bros. Advisors
New York
$4.43M – – –
Renaissance Technologies
31
Renaissance Technologies
New York
$4.39M +$452K +29,600 +15%
Goldman Sachs
32
Goldman Sachs
New York
$4.3M +$1.89M +124,033 +122%
Charles Schwab
33
Charles Schwab
California
$4.14M +$987K +64,721 +42%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$3.85M +$78.4K +5,140 +3%
UONDDL
35
University of Notre Dame du Lac
Indiana
$3.65M +$585K +38,368 +25%
BCPEM
36
Bain Capital Public Equity Management
Massachusetts
$3.44M -$1.62M -106,276 -37%
JP Morgan Chase
37
JP Morgan Chase
New York
$2.88M -$42.7K -2,800 -2%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$2.58M – – –
MIM
39
Monashee Investment Management
Massachusetts
$2.57M – – –
TCIM
40
TIAA CREF Investment Management
New York
$2.1M -$587K -38,475 -26%
Morgan Stanley
41
Morgan Stanley
New York
$1.84M +$707K +46,333 +92%
Principal Financial Group
42
Principal Financial Group
Iowa
$1.83M +$10.3K +676 +0.7%
QI
43
QS Investors
New York
$1.76M -$28.3K -1,858 -2%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.59M +$259K +17,000 +25%
TA
45
Teachers Advisors
New York
$1.44M +$27.2K +1,786 +2%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$1.42M -$1.09M -71,140 -49%
SCA
47
Secor Capital Advisors
New York
$1.33M +$465K +30,470 +77%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.26M -$105K -6,892 -9%
CS
49
Credit Suisse
Switzerland
$1.24M +$72.6K +4,758 +8%
AA
50
ALPS Advisors
Colorado
$1.09M +$73.2K +4,797 +9%
1
2
3 4 5

EPZM Hedge Fund Activity: Q3 2017 in Review

104 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2017, worth a combined $1.15B — up 52% from $757M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of EPZM and 14 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 48 added.

The largest buyer was Fidelity Investments, adding an estimated $68.6M. The largest seller was CQS Cayman, exiting entirely with an estimated $9.28M sold.

  • 104 institutional investors held Epizyme, Inc (EPZM) as of Q3 2017, down from 108 in Q2 2017.
  • Funds reported $1.15B of Epizyme, Inc stock for Q3 2017, up 52% quarter-over-quarter.
  • 14 funds opened new Epizyme, Inc positions in Q3 2017 and 18 closed out, a net change of -4 holders.
  • The largest Epizyme, Inc buyer in Q3 2017 was Fidelity Investments, an estimated $68.6M added.
  • The largest Epizyme, Inc seller in Q3 2017 was CQS Cayman, an estimated $9.28M sold.

Based on aggregated 13F filings for Q3 2017.